Acute heart failure (AHF) represents a potentially fatal disease that needs immediate hospital care. In-hospital management can be divided into three consecutive phases: an early phase of intensive management of symptoms, an intermediate phase of stabilization and transition from intravenous to oral ...
Heart failure is a major and still growing medical and epidemiological problem, but in the last 10-20 years great progress has been made in its treatment. Alleviating symptoms is not (any longer) the only aim of the treatment; improving the life expectation or reducing the mortality has become...
Thus, kidney, heart, and cerebrovascular involvement are discussed first, fol- lowed by pain, sweat function, quality of life, and gastrointestinal symptoms. In some cases, treatment goals are presented without evidence for an effect of ERT. Such is the case when adjunct therapy may be able ...
The ACC Expert Consensus Decision Pathway provides a really nice treatment algorithm for how to progress through getting patients started on and titrated with these agents. An important point Alex mentioned is that, in some other disease state management, we’ll typically start a patient on a medi...
findings indicate that among patients with heart failure, obesity is associated with a higher risk of heart failure hospitalization or death due to cardiac causes. However, achieving biomarker-based treatment goals in heart failure improves the prognosis for patients irrespective of their obesity status...
Heart failure is a commonly encountered clinical syndrome arising from a range of etiologic cardiovascular diseases and manifests in a phenotypic spectrum ... JM Beattie,T Castiello,T Jaarsma - 《Vascular Health & Risk Management》 被引量: 0发表: 2024年 Ultimate technologies and advances for futur...
Chronic heart failure (CHF) is associated with a heavy burden of disease for patients and healthcare professionals. Quality of life and long-term prognosis... T Michal - 《European Heart Journal Supplements》 被引量: 106发表: 2005年 New approaches in the treatment of hepatitis C About 130-17...
There was not consistent evidence of heterogeneity of treatment effects for the outcomes by patient diagnosis (cancer vs no cancer; heart disease vs no heart disease; and lung disease vs no lung disease; eTables 4-6 in Supplement 2). Of these tests for interaction, only 1 statistically signif...
The analyses of the treatment effect modifiers suggested that the intervention had a larger effect size among patients with minoritized race or ethnicity. Among 803 patients with minoritized race or ethnicity, the hospital- and dementia-adjusted proportion with goals-of-care discussions was 10.2% (...
questions have to be debated and resolved before we can define treatment goals more precisely and develop the most appropriate means to achieve them.doi... A Zanchetti - 《American Journal of Medicine》 被引量: 78发表: 1984年 Action video game for wagering where the player's reward to a ...